FCGR3A and Burkitt lymphoma: As it was expected, anti-huCD20(hγ1)-IL2no-alpha increased NK cell activation upon co-incubation with human Burkitt’s lymphoma cells, as shown by the upregulation of CD69, the downregulation of CD16 and increased levels of CD107a (Figure 5).